Cite
HARVARD Citation
Fan, Y. et al. (2021). Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway. Journal of ethnopharmacology. p. . [Online].